Biotechs are having a field day on Wall Street as every day, a new 100% gain is coming across our desks. The unrealistic gains highlight just how unique the current bear market is. Mainly because a worldwide pandemic is not the typical root cause of financial crises. From the oil recession in 1973 to extreme […]
Author Archives: Patrick McLoughlin
ABIO skyrockets 225% today on COVID-19 treatment – have all the gains been made?
An important lesson to understand in investing is that buyers invest in what they believe to be true even if it is false. Biotechs popping up every second and developing a possible COVID-19 treatment is a perfect example. Many investors buy into the biotech on the belief that the company could develop a viable treatment. […]
Mersana Therapeutics reports positive cancer drug results – causing uncontrolled buying.
A cure for cancer is the most desirable statement for scientists and investors alike. However, optimism is often met with disappointment as the task of curing cancer is no easy feat. Despite the difficulty, the scientific world continues to develop drug after drug in an attempt to eradicate the horrific group of diseases. Despite a […]
Novavax’s COVID-19 vaccine enters Phase 1 trials – is Moderna in trouble?
A vaccine is an unlikely solution. However, biotechs often tirelessly work on vaccines even after the expiration date of a virus. For example, vaccines for ebola, Zika, and Sars2 are still in development. Thus if a vaccine is unattainable before COVID-19 fizzles out, biotechs will continue to create a vaccine. Because we do not want […]
Canopy growth soars 53% – is now the time to go pot stock shopping?
The entire cannabis industry is on fire. It might seem weird to see bullish cannabis activity during COVID-19. However, the virus caused the marijuana market to plummet back in February and March. In turn, investors saw unbelievably low prices and went pot stock shopping. The initial recovery of the industry is understandable, considering the main […]
Chinese company shows early signs of promising COVID-19 vaccine.
The vaccine race involves many runners, with the leaders being Moderna (NASDAQ: MRNA), Inovio (NASDAQ: INO), and Novavax (NASDAQ: NVAX). It feels like many vaccine companies are sprinting as they accelerate through the clinical timeline. However, the US government raised the stakes on Thursday when they announced a $1.2 billion injection into AstraZene’s untried vaccine. […]
Potential FDA approval sees Seneca surge 100+%
Seneca Biopharma (NASDAQ: SNCA) came out of the markets storming 100% higher today at $1.67. The volcanic surge is off the back on no news, leaving investors confused. SNCA forums on Yahoo Finance and Stockwits are flooded with the same question “why is SNCA up”? Why is Seneca surging? The unsureness of why SNCA is […]
Nano Dimension surges 400% off 3D printing breakthrough.
3D printing is tomorrow’s technological future. The technology is new and creates an itch in the minds of investors, consumers, and the government. The new wave of 3D printers can fabricate anything from keyboards to human body parts. It seems the possible creations are limitless. Making it fair to say that 3D printing is and […]
Novavax look to repeat last week’s 120% gain.
Novavax (NASDAQ:NVAX) look to surge come market open with pre-market up 13% (at the time of writing). Novavax captured the wallets of investors last week when they received $384 million in vaccine funding from CEPI. This week NVAX is expected to captivate investors with a new all-time-high. Which seems achievable, especially if last week’s insane […]
BREAKING: SRNE’s COVID-19 treatment offers 100% protection – is now the time to invest?
It seems most biotechs are reenacting the boy who cried wolf. Especially, as every week a new biotech enters the headlines for COVID-19 vaccine developments. In all honesty a single viable vaccine, let alone multiple, is unlikely. Testing and treatments is where is the consistent share price growth resides. Thus, when a COVID-19 treatment posts […]
Mesoblast set to surge off COVID-19 stem cell trials.
The world is in dire need of a COVID-19 treatment. A vaccine is the plan b for the long-term. However, governments can take action immediately through COVID-19 treatments and testing. Mesoblast (NASDAQ:MESO) and (ASX:MSB), an Australian biotech is developing a stem cell treatment (Remestemcel-L), for COVID-19. The primary reason people die from COVID-19 is due […]
CODX up 2000% and looking to pioneer COVID-19 testing.
The biotech world is in a frenzy. Testing kit and vaccine companies are experiencing extreme investor backing. Despite occasional pump and dumps, the explosive share price growth for biotechs is continuing. However, a vaccine is not the answer because time is not on our side. Also, if you look at Ebola, Zika, and Sars2, a […]
Moderna (MRNA) set to cure COVID-19 – is now the time to invest?
MRNA’s key COVID-19 developments so far US government is willing to fund mRNA-173 through every trial until regulatory approval. Biomedical Advanced Research and Development Authority (BARDA) is ready to give Moderna (NASDAQ: MRNA) $483 million to expedite mRNA-173 through clinical development. Lonza Group, via its agreement with Moderna, is manufacturing mRNA-173 at their US and […]
Is BBUS the best way to make money during the crash?
Every investor must understand bulls and bears make money, but pigs get slaughtered. In other words, you can profit when the market goes up or down, but if you are too greedy, you will get burned. We are in a down market (opinion, not advice). Yes, there are bullish recoveries. However, these are known as […]
Wayfair is surging like a rocket – positive earnings could launch W into the stratosphere.
Wayfair (NYSE: W), the gigantic e-commerce store that sells a zillion amount of furniture and home goods, is rocking the investment world. Flashback three weeks ago and COVID-19 pulled Wayfair down to the $25 mark. Let me stress the significance of this bearish decline, $25 equated to a 5 year low. Investors saw the opportunity […]
Is ASX: OOO the riskiest or smartest oil investment?
Ever since oil plunged into negative territory, every man and his dog became interested in oil investments. Negative oil future contracts created a frenzy of buyers around ASX ETF OOO. There's been an extraordinary collapse in the price of oil in the United States with crude dropping below $1 a barrel, and at one point […]
Westpac’s profit plunges by 62% – Is a long term investment pointless?
First, it was NAB, then ANZ and now Westpac (ASX:WBC) . The stereotypical safe investments are not looking so safe anymore. Profit plunges, dividend cuts, and frozen mortgage paymentsscream banking instability. Westpac’s $23 million lawsuit for money laundering, sex trafficking, and terrorism was bad enough. However, the dire consequences of COVID-19 could be the straw that […]
Carnival Cruises and Royal Caribbean could go bankrupt – is there any hope?
Carnival Cruise (NYSE: CCL) and Royal Caribbean (NYSE: RCL) experienced extreme turbulence over the past few months. Especially, as the short term future of international travel dims. It seems the cruise line industry, as mentioned by Buffet, will never be the same again. Since our last article on investing in CCL and RCL, both stock […]
2 Oil Stocks that hold huge upside potential.
Flashback to last Tuesday and oil plummeted to a historic low. Oil dropped into negative territory. Instantly, people that’s great. Because companies like BHP will pay me to take barrels of oil off their hands, right? Unfortunately, the idea of being paid to take oil is unrealistic for the average Joe. Where would you store […]
Here’s why Clinuvel could skyrocket this week?
Clinuvel (ASX: CUV), arguably one the best biotechs on the market, is trading at 35-40% of its true value (based on my research, not advice). CUV specialise in treating patients who suffer from severe skin disorders. If the name CUV or Clinuvel sounds foreign, then I suggest reading our digestible, free and extensive report here. […]